Ascendis Pharma A/S - ADR
ASND
Market Cap$10.52B
Close$
$158.03
9.3% downside
Current Fair Value
9.3% downsideOvervalued by 9.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.52 Billion |
|---|---|
| Enterprise Value | $10.85 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-6.53 |
| Beta | 0.36 |
| Outstanding Shares | 60,018,550 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -25.98 |
|---|---|
| PEG | 93.5 |
| Price to Sales | 29.03 |
| Price to Book Ratio | -43.55 |
| Enterprise Value to Revenue | 29.41 |
| Enterprise Value to EBIT | -36.41 |
| Enterprise Value to Net Income | -32 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | -4.48 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ascendis Pharma A/S
CEO: Jan Moeller Mikkelsen